George Gibbons - Publications
Affiliations: | University of Cambridge, Cambridge, England, United Kingdom |
Year | Citation | Score | |||
---|---|---|---|---|---|
2023 | Szebényi K, Barrio-Hernandez I, Gibbons GM, Biasetti L, Troakes C, Beltrao P, Lakatos A. A human proteogenomic-cellular framework identifies KIF5A as a modulator of astrocyte process integrity with relevance to ALS. Communications Biology. 6: 678. PMID 37386082 DOI: 10.1038/s42003-023-05041-4 | 0.637 | |||
2021 | Szebényi K, Wenger LMD, Sun Y, Dunn AWE, Limegrover CA, Gibbons GM, Conci E, Paulsen O, Mierau SB, Balmus G, Lakatos A. Human ALS/FTD brain organoid slice cultures display distinct early astrocyte and targetable neuronal pathology. Nature Neuroscience. 24: 1542-1554. PMID 34675437 DOI: 10.1038/s41593-021-00923-4 | 0.474 | |||
2019 | Giandomenico SL, Mierau SB, Gibbons GM, Wenger LMD, Masullo L, Sit T, Sutcliffe M, Boulanger J, Tripodi M, Derivery E, Paulsen O, Lakatos A, Lancaster MA. Cerebral organoids at the air-liquid interface generate diverse nerve tracts with functional output. Nature Neuroscience. 22: 669-679. PMID 30886407 DOI: 10.1038/S41593-019-0350-2 | 0.469 | |||
2017 | Tyzack GE, Hall CE, Sibley CR, Cymes T, Forostyak S, Carlino G, Meyer IF, Schiavo G, Zhang SC, Gibbons GM, Newcombe J, Patani R, Lakatos A. A neuroprotective astrocyte state is induced by neuronal signal EphB1 but fails in ALS models. Nature Communications. 8: 1164. PMID 29079839 DOI: 10.1038/S41467-017-01283-Z | 0.663 | |||
Show low-probability matches. |